4.6 Article

Long Noncoding RNA HOTAIR Is a Prognostic Marker for Esophageal Squamous Cell Carcinoma Progression and Survival

期刊

PLOS ONE
卷 8, 期 5, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0063516

关键词

-

资金

  1. National Natural Science Foundation of China [81102023, 30973505]
  2. Foundation of Ministry of Education of the People's Republic of China [20120171110075]
  3. Guangdong Natural Science Foundation [S2011040004481, 7001618]
  4. Foundation of Guangzhou Science and Technology Bureau [2009Y-C011-1, 2008B030301135]
  5. Sun Yat-Sen University [12ykpy32]

向作者/读者索取更多资源

Background: It is currently unclear whether the expression of HOX transcript antisense RNA (HOTAIR) correlates with the progression of esophageal cancer. The aim of this study was to examine HOTAIR expression in patients with esophageal squamous cell cancer (ESCC) and explore its clinical significance. Methods: Differences in the expression of HOTAIR were examined via in situ hybridization (ISH) and quantitative reverse transcriptase PCR (qRT-PCR). The prognostic significance was evaluated using Kaplan-Meier and Cox regression analyses. Proliferation, colony formation and migration assays were performed in ESCC cell lines to determine the function of HOTAIR in the progression of ESCC in vitro. Results: A notably higher level of HOTAIR expression was found in ESCC tissues. High expression levels of HOTAIR in ESCC patients correlated positively with clinical stage, TNM classification, histological differentiation and vital status. HOTAIR expression was found to be an independent prognostic factor in ESCC patients. ESCC patients who expressed high levels of HOTAIR had substantially lower overall 5-year survival rates than HOTAIR-negative patients. In vitro assays of ESCC cell lines demonstrated that HOTAIR mediated the proliferation, colony formation and migratory capacity of ESCC cells. Conclusion: HOTAIR is a potential biomarker for ESCC prognosis, and the dysregulation of HOTAIR may play an important role in ESCC progression.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer

Qingjian Li, Tao Qin, Zhuofei Bi, Huangming Hong, Lin Ding, Jiewen Chen, Wei Wu, Xiaorong Lin, Wenkui Fu, Fang Zheng, Yandan Yao, Man-Li Luo, Phei Er Saw, Gerburg M. Wulf, Xiaoding Xu, Erwei Song, Herui Yao, Hai Hu

NATURE COMMUNICATIONS (2020)

Article Oncology

Re-excision or wait and watch-a prediction model in breast phyllodes tumors after surgery

Xue Chao, Xiaoyan Jin, Cui Tan, Peng Sun, Junwei Cui, Hui Hu, Qian Ouyang, Kai Chen, Wei Wu, Zhanghai He, Yan Nie, Herui Yao

ANNALS OF TRANSLATIONAL MEDICINE (2020)

Article Cell Biology

Enhancer-Driven lncRNA BDNF-AS Induces Endocrine Resistance and Malignant Progression of Breast Cancer through the RNH1/TRIM21/mTOR Cascade

Xiaorong Lin, Xiaoxiao Dinglin, Siting Cao, Senyou Zheng, Cheng Wu, Wenying Chen, Qingjian Li, Qian Hu, Fang Zheng, Zhiyong Wu, De-Chen Lin, Yandan Yao, Xiaoding Xu, Zhi Xie, Qiang Liu, Herui Yao, Hai Hu

CELL REPORTS (2020)

Article Chemistry, Multidisciplinary

Nanoparticles (NPs)-Meditated LncRNA AFAP1-AS1 Silencing to Block Wnt/β-Catenin Signaling Pathway for Synergistic Reversal of Radioresistance and Effective Cancer Radiotherapy

Zhuofei Bi, Qingjian Li, Xiaoxiao Dinglin, Ying Xu, Kaiyun You, Huangming Hong, Qian Hu, Wei Zhang, Chenchen Li, Yujie Tan, Ning Xie, Wei Ren, Chuping Li, Yimin Liu, Hai Hu, Xiaoding Xu, Herui Yao

ADVANCED SCIENCE (2020)

Letter Oncology

Joint association of patients' sex and PD-L1 expression with overall survival benefits and tumor-immune microenvironment in immune checkpoint inhibitors for cancers

Anlin Li, Yongjian Chen, Wenda Zhang, Haitao Zhong, Qiyun Ou, Yang Gu, Junqing Xia, Dagui Lin, Tuping Fu, Ruixin Liu, Hai Hu, Yunfang Yu, Herui Yao

CLINICAL AND TRANSLATIONAL MEDICINE (2020)

Letter Oncology

Novel blood-based tumor mutation algorithm and nomogram predict survival of immune checkpoint inhibitor in non-small-cell lung cancer: Results from two multicenter, randomized clinical trials

Yunfang Yu, Yongjian Chen, Anlin Li, Qiyun Ou, Qingjian Li, Yang Gu, Dagui Lin, Wenda Zhang, Jingshu Wang, Xudong Tang, Zhihua Li, Hai Hu, Herui Yao

CLINICAL AND TRANSLATIONAL MEDICINE (2020)

Editorial Material Medicine, General & Internal

Association of Immune Checkpoint Inhibitor Therapy With Survival in Patients With Cancers With MUC16 Variants

Yunfang Yu, Dagui Lin, Anlin Li, Yongjian Chen, Qiyun Ou, Hai Hu, Herui Yao

JAMA NETWORK OPEN (2020)

Article Medicine, General & Internal

Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer

Yunfang Yu, Yujie Tan, Chuanmiao Xie, Qiugen Hu, Jie Ouyang, Yongjian Chen, Yang Gu, Anlin Li, Nian Lu, Zifan He, Yaping Yang, Kai Chen, Jiafan Ma, Chenchen Li, Mudi Ma, Xiaohong Li, Rong Zhang, Haitao Zhong, Qiyun Ou, Yiwen Zhang, Yufang He, Gang Li, Zhuo Wu, Fengxi Su, Erwei Song, Herui Yao

JAMA NETWORK OPEN (2020)

Article Oncology

Clinical Evidence for Locoregional Surgery of the Primary Tumor in Patients with De Novo Stage IV Breast Cancer

Yunfang Yu, Huangming Hong, Ying Wang, Tuping Fu, Yongjian Chen, Jianli Zhao, Peixian Chen, Ruizhao Cai, Yujie Tan, Zifan He, Wei Ren, Lihuan Zhou, Junhao Huang, Jun Tang, Guolin Ye, Herui Yao

Summary: This study found that locoregional surgery did not improve overall survival compared to no surgery in de novo stage IV breast cancer patients, but it did result in longer locoregional progression-free survival. Patients with bone-only metastasis tended to benefit from surgery in terms of overall survival.

ANNALS OF SURGICAL ONCOLOGY (2021)

Article Medicine, General & Internal

Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study

Yunfang Yu, Zifan He, Jie Ouyang, Yujie Tan, Yongjian Chen, Yang Gu, Luhui Mao, Wei Ren, Jue Wang, Lili Lin, Zhuo Wu, Jingwen Liu, Qiyun Ou, Qiugen Hu, Anlin Li, Kai Chen, Chenchen Li, Nian Lu, Xiaohong Li, Fengxi Su, Qiang Liu, Chuanmiao Xie, Herui Yao

Summary: Machine learning techniques were used to develop an efficient preoperative MRI radiomics evaluation approach for predicting ALN status in early-stage invasive breast cancer patients. The multiomic signature showed a high prediction quality and potential for tailored surgical management.

EBIOMEDICINE (2021)

Article Oncology

Magnetic resonance imaging radiomics signatures for predicting endocrine resistance in hormone receptor-positive non-metastatic breast cancer

Yaping Yang, Junwei Li, Yajing Liu, Ying Zhong, Wei Ren, Yujie Tan, Zifan He, Chenchen Li, Jie Ouyang, Qiugen Hu, Yunfang Yu, Herui Yao

Summary: This study developed and validated a combined radiomic-clinical model using preoperative multiparametric MRI to predict endocrine resistance in non-metastatic breast cancer patients, showing superior performance compared to clinical and radiomic models alone in both training and validation cohorts.

BREAST (2021)

Article Oncology

LncRNA Uc003xsl.1-Mediated Activation of the NFKB/IL8 Axis Promotes Progression of Triple-Negative Breast Cancer

Ying Xu, Wei Ren, Qingjian Li, Chaohui Duan, Xiaorong Lin, Zhuofei Bi, Kaiyun You, Qian Hu, Ning Xie, Yunfang Yu, Xiaoding Xu, Hai Hu, Herui Yao

Summary: This study identifies an epigenetic-driven NF kappa B/IL8 cascade initiated by a lncRNA, whose aberrant activation contributes to tumor metastasis and poor survival in patients with triple-negative breast cancer.

CANCER RESEARCH (2022)

Article Oncology

Identification of DHX36 as a tumour suppressor through modulating the activities of the stress-associated proteins and cyclin-dependent kinases in breast cancer

Yinduo Zeng, Tao Qin, Valentina Flamini, Cui Tan, Xinke Zhang, Yizi Cong, Emily Birkin, Wen G. Jiang, Herui Yao, Yuxin Cui

AMERICAN JOURNAL OF CANCER RESEARCH (2020)

Article Oncology

Development and validation of a nomogram in survival prediction among advanced breast cancer patients

Jianli Zhao, Yaping Yang, Danmei Pang, Yunfang Yu, Xiao Lin, Kai Chen, Guolin Ye, Jun Tang, Qian Hu, Jie Chai, Zhuofei Bi, Linxiaoxiao Ding, Wenjing Wu, Yinduo Zeng, Xiujuan Gui, Donggeng Liu, Herui Yao, Ying Wang

ANNALS OF TRANSLATIONAL MEDICINE (2020)

Article Medicine, General & Internal

Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer

Yunfang Yu, Wenda Zhang, Anlin Li, Yongjian Chen, Qiyun Ou, Zifan He, Yiwen Zhang, Ruixin Liu, Herui Yao, Erwei Song

JAMA NETWORK OPEN (2020)

暂无数据